Administration of tissue plasminogen activator (tPA) is the most effective treatment option for cerebral ischemia several years ago [5], but its use is limited to a narrow window after the onset of stroke, as the risk of hemorrhagic transformation increases over time, causing increased brain damage. This evidence concerns the gene PLAT and brain ischemia.